CD44 and breast carcinoma: Previously reported putative CSCs markers for other solid tumors (CD44 in breast cancer and CD133 in brain tumor) were used to identify HN-/OSCC CSCs and then isolated and xenotransplanted in mice to observe for tumor formation.